Product Information
ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.6077 per EA under NDC 00904721304. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
333 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904721304
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACAMPROSATE CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202229On Market Since
7/16/2013
Price Statistics
The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 210 times since Jun 22, 2022, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6077 per EA |
|---|---|
| All-time high | $0.6391 (Sep 14, 2022) |
| All-time low | $0.2971 (Nov 20, 2024) |
| 52-week high | $0.6218 |
| 52-week low | $0.5580 |
| Median price | $0.5338 |
| Average price | $0.5280 |
| Largest weekly change | +76.4% (Feb 12, 2025) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Major Pharmaceuticals, is $0.6077 per EA (NDC 00904721304), effective Jun 24, 2026.
How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?
Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has risen 14.2%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?
Since Jun 22, 2022, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.2971 (Nov 20, 2024) to a high of $0.6391 (Sep 14, 2022), with a median of $0.5338 per EA.
Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ACAMPROSATE CALC DR 333 MG TAB, but none are currently priced below it.
Who manufactures ACAMPROSATE CALC DR 333 MG TAB?
ACAMPROSATE CALC DR 333 MG TAB (NDC 00904721304) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification